← Evidence map

ArticlePharmacoEconomics - open2024

Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses.

Fatemeh Mirzayeh Fashami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers' Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses. | Socratic